STEMI HUSOP DA5

Card Set Information

Author:
HUSOP2014
ID:
177723
Filename:
STEMI HUSOP DA5
Updated:
2012-10-15 01:57:50
Tags:
STEMI HUSOP DA5
Folders:

Description:
STEMI HUSOP DA5
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user HUSOP2014 on FreezingBlue Flashcards. What would you like to do?


  1. Cardiac cell wall injury biochemical markers include:
    • troponin I
    • troponin T
    • creatine kinase (CK)
  2. What drug is used for chest pain not controlled by NTG?
    morphine
  3. Metoprolol is selective for 
    beta 1
  4. Metoprolol IV dose is ______ the PO dose.
    1/10
  5. Occasionally, __________ is given in the peri-infarction period especially when left ventricular dysfunction is present (EF <40%)
    carvedilol
  6. Use oxygen only if patient is __________
    hypoxic
  7. Hyperoxia is defined as
    Pa02 > 300mm/Hg
  8. _____________ can be used for immediate relief of angina or prophylaxis prior to anginal causing activities
    NTG
  9. Patients must have a nitrate free period of___________ in order to prevent _____________
    •  8 to 12 hours
    • nitrate tolerance 
  10. The ASA dose should be between _______ and ___________
    • 162mg
    • 325mg
  11. ASA produces a rapid clinic antithrombotic effect caused by immediate and near total inhibition of ____________ production
    thromboxane A2
  12. Ticagrelor cannot be given with more than ____ ASA per day
     81mg
  13. Omeprazole inhibits ________ which reduces the effectivesness of _______________ and ___________.
    • CYP2C19
    • clopidogrel
    • prasugrel
  14. P2Y12 antagonists include
    • ticagelor
    • clopidogrel
    • prasugrel
    • ticlopidine
  15. Thienopyridines include
    • ticlopidine
    • prasugrel
    • clopdidogrel
  16. Direct Thrombin Inhibitors Include
    • bivlirudin
    • enoxiparin
    • unfractionated heparin
    • dalteparin
    • fondaparinux
  17. _____________ prevent new thrombus from being formed, but do not have much effect on thrombus already formed.
    Direct thrombin inhibitors 
  18. ___________, an IV DTI is commonly used in conjuction with “bail-out” _____________ (small single boluses) as it has a lower bleeding profile and carries no potential for heparin-induced _______________
    • Bivalirudin
    • IIB/IIIa
    • thrombocytopenia
  19. IIB/IIIa agents include
    • eptifibatide
    • abciximab
    • tirofiban
  20. Statin PCI therapy should consist of __________ pretreatment and _____________ post PCI.
    • atorvastatin 80mg
    • atorvastatin 10mg
  21. Monitoring for effect of thrombolysis or angioplasty
    • Monitor ST segment elevations
    • Monitor EKG ST segment resolution- looking for at least a 50% reduction in the size ofthe initial ST segment elevation
    • Monitor cardiac rhythm for 3 hours
    • Monitor clinical signs, BP, chest pain, etc.
  22. An ______________ should be prescribed for patients with a diminished ejection fraction (< 40%) post-MI 
    aldosterone antagonist
  23. ___________ or _____________ should be considered in all patients.
    • ACE-Is
    • ARBs
  24. avoid ___________ if Scr>2.5mg/dl in men and 2.0mg/dl in women of CrCl < 30ml/min AND on ACE-I/ARB but does NOT have hyperkalemia (K>5meq/L)
    aldosterone antagonist
  25. Post MI complication include
    • 1. pump failure = heart failure
    • 2. arrhythmias
    • 3. recurrent ischemia an reinfarction.
    • 4. pericarditis
    • 5. sudden cardiac death

What would you like to do?

Home > Flashcards > Print Preview